Mgr. Helena Peschelová
odborná pracovnice - PhD studentka – Výzkumná skupina Michala Šmídy
kancelář: bud. E35/142
Kamenice 753/5
625 00 Brno
telefon: | 549 49 5875 |
---|---|
e‑mail: |
Počet publikací: 25
2021
-
Drug repositioning in genetically defined CLL cases reveals a potentional novel therapeutic use for approved drugs.
Rok: 2021, druh: Konferenční abstrakty
-
Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro
Journal for ImmunoTherapy of Cancer, rok: 2021, ročník: 9, vydání: 8, DOI
-
In vivo antigen-negative escape to CART-19 caused by CD19 promotor hypermethylation.
Rok: 2021, druh: Konferenční abstrakty
2020
-
CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells
Plos one, rok: 2020, ročník: 15, vydání: 3, DOI
-
Combination of epigenetic drug screen and CRISPR knockout screen revealed involvement of aurora kinases and Cullin 3 in CD20 regulation
Rok: 2020, druh: Konferenční abstrakty
-
CRISPR/CAS9 technology: a useful tool in the study of chronic lymphocytic leukemia
Rok: 2020, druh: Konferenční abstrakty
-
Genome-wide CRISPR/Cas9 screening reveals novel target genes, whose inactivation is able to upregulate surface expression of immunotherapy target CD20
Rok: 2020, druh: Konferenční abstrakty
-
Impact of genetics on the performance of anti-CD 19 chimeric antigen receptor T cells in chronic lymphocytic leukemia
Rok: 2020, druh: Konferenční abstrakty
-
Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia
Journal for ImmunoTherapy of Cancer, rok: 2020, ročník: 8, vydání: 1, DOI
-
The use of CRISPR/Cas9 technology in the study of chronic lymphocytic leukemia.
Rok: 2020, druh: Konferenční abstrakty